Gavriilidis, Prodromos
Koole, Michel
Mottaghy, Felix M.
Jansen, Floris P.
Wierts, Roel https://orcid.org/0000-0002-9955-8754
Article History
Received: 1 May 2025
Accepted: 3 July 2025
First Online: 28 July 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval for this study was granted by the medical ethics committee METC azM/UM, Maastricht, The Netherlands (Date: 09-July-2021, No: 2021-2795).
: Written informed consent was obtained from all individual participants included in the study.
: Informed consent was obtained from all participants to publish their anonymized data.
: Felix M. Mottaghy reports institutional grants/contracts from GE Precision Healthcare LLC, NanoMab Technology Ltd., Radiopharm Ltd., and Siemens Healthcare; and personal/consulting fees from Advanced Accelerator Applications (AAA) GmbH/Novartis, CURIUMTM, NanoMab Technology Ltd., and Telix Pharmaceuticals outside the submitted work. Floris P. Jansen is employee of GE HealthCare. The other authors have no relevant financial or non-financial interests to disclose regarding this topic.